Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chakravarty

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Arthritis Research & Therapy|June 9, 2023
Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world studyLaure Gossec, Elke Theander, Soumya D Chakravarty, et al.
Drug Safety|February 11, 2019
Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development ProgramsSubrata Ghosh, Lianne S Gensler, Zijiang Yang, et al.
BMC Rheumatology|December 5, 2019
Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologicsChristopher T Ritchlin, Mona Stahle, Yves Poulin, et al.
Drug Safety|April 24, 2019
Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development ProgramsSubrata Ghosh, Lianne S Gensler, Zijiang Yang, et al.
ACR Open Rheumatology|October 19, 2020
Evaluation of Improvement in Skin and Nail Psoriasis in Bio-naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO-VIBRANT StudyPhilip Mease, M Elaine Husni, Soumya D Chakravarty, et al.
Infection and Immunity|January 24, 2008
Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungsSoumya D Chakravarty, Guofeng Zhu, Ming C Tsai, et al.
Clinical Rheumatology|February 29, 2020
A systematic review and network meta-analysis of current and investigational treatments for active ankylosing spondylitisA Deodhar, S D Chakravarty, C Cameron, et al.
Rheumatology Advances in Practice|May 20, 2024
BASDAI versus ASDAS in evaluating axial involvement in patients with psoriatic arthritis: a pooled analysis of two phase 3 studiesXenofon Baraliakos, Dafna D Gladman, Soumya D Chakravarty, et al.
Arthritis Research & Therapy|August 16, 2023
Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b studyGeorg Schett, Warner Chen, Sheng Gao, et al.
The Journal of Rheumatology|August 15, 2022
Women With Psoriatic Arthritis Experience Higher Disease Burden Than Men: Findings From a Real-World Survey in the United States and EuropeLaure Gossec, Jessica A Walsh, Kaleb Michaud, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Arthritis Research & Therapy|June 9, 2023
Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world studyLaure Gossec, Elke Theander, Soumya D Chakravarty, et al.
Drug Safety|February 11, 2019
Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development ProgramsSubrata Ghosh, Lianne S Gensler, Zijiang Yang, et al.
BMC Rheumatology|December 5, 2019
Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologicsChristopher T Ritchlin, Mona Stahle, Yves Poulin, et al.
Drug Safety|April 24, 2019
Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development ProgramsSubrata Ghosh, Lianne S Gensler, Zijiang Yang, et al.
ACR Open Rheumatology|October 19, 2020
Evaluation of Improvement in Skin and Nail Psoriasis in Bio-naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO-VIBRANT StudyPhilip Mease, M Elaine Husni, Soumya D Chakravarty, et al.
Infection and Immunity|January 24, 2008
Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungsSoumya D Chakravarty, Guofeng Zhu, Ming C Tsai, et al.
Clinical Rheumatology|February 29, 2020
A systematic review and network meta-analysis of current and investigational treatments for active ankylosing spondylitisA Deodhar, S D Chakravarty, C Cameron, et al.
Rheumatology Advances in Practice|May 20, 2024
BASDAI versus ASDAS in evaluating axial involvement in patients with psoriatic arthritis: a pooled analysis of two phase 3 studiesXenofon Baraliakos, Dafna D Gladman, Soumya D Chakravarty, et al.
Arthritis Research & Therapy|August 16, 2023
Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b studyGeorg Schett, Warner Chen, Sheng Gao, et al.
The Journal of Rheumatology|August 15, 2022
Women With Psoriatic Arthritis Experience Higher Disease Burden Than Men: Findings From a Real-World Survey in the United States and EuropeLaure Gossec, Jessica A Walsh, Kaleb Michaud, et al.
Pageof 10